Iurii Titarenko

English · Українська · Español · Français · Deutsch · Português

Iurii Titarenko, also published as Yurii Titarenko (Ukrainian name in its original script: Тітаренко Юрій Анатолійович), is a contributor to publications on digital-health technologies, pharmaceutical research and medicines regulation. His identity anchor is ORCID 0009-0002-8664-9013, linked in publisher author records.

Dated institutional context

The SRUMPL management page, marked updated 16 May 2026, lists him as Head of Scientific Sector of Innovative Digital Medical Technologies, PhD in Psychology. This is the role stated by that institutional source; it does not establish medical licensure or a clinical specialty.

Documented collaborative work

• 2024, falsified-medicine risks: Yurii Titarenko and Valentyn Shapovalov, The Latest Quantum and Medical, Quantum and Pharmaceutical Technologies in Countering the Criminal and Legal, Forensic and Pharmaceutical Risks of Circulation of Falsified Drugs. Primary record, DOI 10.53933/sspmlp.v4i2.149. This documents the authors' proposed technology-related approach, not demonstrated effectiveness.
• 2024, formulation and quality: Valentyn Shapovalov, Viktoriia Shapovalova, Alina Osyntseva, Valerii Shapovalov, Oleksandr Veits and Yurii Titarenko, Multidisciplinary context of research of a new drug in infectious and inflammatory diseases. Primary record, DOI 10.5281/zenodo.13820208. The work concerns paracetamol/ascorbic-acid tablets, standardization and quality control; it is not a clinical efficacy trial.
• 2025, antituberculosis medicines: Oleksandr Nevzghoda, Alina Osyntseva, Valentyn Shapovalov, Iurii Titarenko, Viktoria Dovzhuk, Viktoriia Shapovalova and Valerii Shapovalov, Content analysis of combined anti-tuberculosis drugs. Primary record, DOI 10.5281/zenodo.15662640. This is a medicines-market, registration and formulary analysis.

Individually authored publications

• 2026: The Role of Digital Health Technology in Personalized Allergy Therapy, published 16 March 2026, 6(1):102–118. Primary record, DOI 10.53933/wv26wm48. This narrative review uses content analysis, SWOT and PESTEL to discuss telemedicine, telepharmacy, AI, wearables, pharmacogenetics and personalized care. Its abstract calls for further clinical research and regulation.
• 2025: Plasma Medicine: Innovative Methods of Diagnosis and Treatment of Chronic Wounds and Oncological Diseases. Primary record, DOI 10.53933/sspmpm.v5i1.174.
• 2024: Application of Innovative Digital Medical Technologies of Bioquantum Medicine and Therapy in Elimination of Allergy Symptoms. Primary record, DOI 10.53933/sspmpm.v4i3.156.
• 2024: Bioresonance Therapy as an Innovative Method of Bioquantum Medicine. Primary record, DOI 10.53933/sspmpm.v4i4.166.

Evidence and attribution

The bioresonance and “bioquantum medicine” titles are catalogued as the author's publications and claims, not as established clinical treatment effectiveness. Digital-health tools, plasma research and bioresonance are distinct topics; their inclusion in one author's bibliography does not give them the same evidence base. This entry is a publication guide, not treatment advice.

Coauthorship establishes a connection on the cited work, not supervision, equal contribution or endorsement of all later concepts. No personal ResearchGate or Google Scholar profile is linked without a secure identity match. See Research network and People and attribution.

Earlier bibliographic record

A 2015 Ukrainian Medical Journal review cites Yu. A. Titarenko, E. G. Chuprikova and A. P. Chuprikov (2005), Psychological Stress and Stress-Analysis (editorial English translation; original: Психологический стресс и стресс-анализ), Kyiv. This documents an earlier work through a later published reference; it does not mean the original book was examined here. No clinical-effectiveness or specific intellectual-genealogy claim is inferred. See Research before 2021.